PubRank

Julie M Decker

Author PubWeight™ 153.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibody neutralization and escape by HIV-1. Nature 2003 21.48
2 Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 2008 16.54
3 Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 2005 15.61
4 Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002 13.91
5 Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004 8.60
6 Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 2009 7.01
7 Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol 2008 5.69
8 Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J Virol 2006 5.25
9 Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors. J Virol 2007 4.45
10 High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog 2010 3.68
11 A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. Virology 2006 3.26
12 Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med 2002 3.04
13 Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein. J Virol 2005 2.89
14 Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci U S A 2013 2.75
15 Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J Virol 2006 2.41
16 In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth. J Virol 2009 2.29
17 Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth. Structure 2005 2.09
18 Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7. PLoS Pathog 2012 1.88
19 Adaptation of HIV-1 to its human host. Mol Biol Evol 2007 1.77
20 Origin and biology of simian immunodeficiency virus in wild-living western gorillas. J Virol 2008 1.76
21 Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. AIDS Res Hum Retroviruses 2003 1.73
22 Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J Virol 2007 1.70
23 Ancestral and consensus envelope immunogens for HIV-1 subtype C. Virology 2006 1.62
24 Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog 2012 1.61
25 High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination. Virology 2009 1.58
26 Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections. PLoS Pathog 2011 1.57
27 Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins. J Virol 2011 1.55
28 Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins. Virology 2006 1.51
29 Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma. J Virol 2008 1.44
30 Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees. J Virol 2007 1.36
31 Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. J Virol 2003 1.28
32 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response. J Virol 2007 1.26
33 Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock. J Virol 2013 1.18
34 Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones. Virology 2012 1.18
35 Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein. J Mol Biol 2008 1.14
36 Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir. J Virol 2012 1.13
37 Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site. J Virol 2004 1.13
38 Primary infection by a human immunodeficiency virus with atypical coreceptor tropism. J Virol 2011 1.12
39 Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome. Retrovirology 2012 1.10
40 A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays. Virology 2009 1.02
41 Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection. J Virol 2011 0.96
42 Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation. J Clin Invest 2012 0.95
43 4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms. PLoS One 2010 0.91
44 Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies. J Virol 2012 0.90